Imatinib Active Not Recruiting Phase 1 Trials for Malignancies, Hematologic Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02352558A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies